Guidelines and literature
Oncology and PET/CT Gallery
- 2018
FDG-PET/CT for treatment response assessment in head and neck squamous cell carcinoma: a systematic review and meta-analysis of diagnostic performance.
Helsen, N., Van den Wyngaert, T., Carp, L., & Stroobants, S. (2018). FDG-PET/CT for treatment response assessment in head and neck squamous cell carcinoma: a systematic review and meta-analysis of diagnostic performance. Eur J Nucl Med Mol Imaging, 45(6), 1063-1071. doi:10.1007/s00259-018-3978-3
- 2018
FDG-PET/CT for treatment response assessment in head and neck squamous cell carcinoma: a systematic review and meta-analysis of diagnostic performance.
Helsen, N., Van den Wyngaert, T., Carp, L., & Stroobants, S. (2018). FDG-PET/CT for treatment response assessment in head and neck squamous cell carcinoma: a systematic review and meta-analysis of diagnostic performance. Eur J Nucl Med Mol Imaging, 45(6), 1063-1071. doi:10.1007/s00259-018-3978-3
- 2018
Fully Automated Delineation of Gross Tumor Volume for Head and Neck Cancer on PET-CT Using Deep Learning: A Dual-Center Study.
Huang, B., Chen, Z., Wu, P. M., Ye, Y., Feng, S. T., Wong, C. O., . . . Huang, B. (2018). Fully Automated Delineation of Gross Tumor Volume for Head and Neck Cancer on PET-CT Using Deep Learning: A Dual-Center Study. Contrast Media Mol Imaging, 2018, 8923028. doi:10.1155/2018/8923028
- 2018
Guidelines on nuclear medicine imaging in neuroblastoma
Bar-Sever, Z. B., Lorenzo: Shulkin, Barry: Kong, Grace: Hofman, Michael S: Lopci, Egesta: Manea, Irina: Koziorowski, Jacek: Castellani, Rita: Boubaker, Ariane. (2018). Guidelines on nuclear medicine imaging in neuroblastoma. European Journal of Nuclear Medicine and Molecular Imaging, 45(11), 2009-2024. Retrieved from https://link.springer.com/content/pdf/10.1007%2Fs00259-018-4070-8.pdf
- 2018
How to use PET/CT in the evaluation of response to radiotherapy.
Decazes, P., Thureau, S., Dubray, B., & Vera, P. (2018). How to use PET/CT in the evaluation of response to radiotherapy. Q J Nucl Med Mol Imaging, 62(2), 152-164. doi:10.23736/s1824-4785.17.03033-3
- 2018
Immunotherapy and the role of imaging.
Carter, B. W., Bhosale, P. R., & Yang, W. T. (2018). Immunotherapy and the role of imaging. Cancer, 124(14), 2906-2922. doi:10.1002/cncr.31349
- 2018
Interobserver Agreement of Interim and End-of-Treatment 18F-FDG PET/CT in Diffuse Large B-Cell Lymphoma: Impact on Clinical Practice and Trials.
Burggraaff, C. N., Cornelisse, A. C., Hoekstra, O. S., Lugtenburg, P. J., De Keizer, B., Arens, A. I. J., . . . Zijlstra, J. M. (2018). Interobserver Agreement of Interim and End-of-Treatment (18)F-FDG PET/CT in Diffuse Large B-Cell Lymphoma: Impact on Clinical Practice and Trials. J Nucl Med, 59(12), 1831-1836. doi:10.2967/jnumed.118.210807
- 2018
Interventional locoregional treatment and metabolic response: advantages of using PET/CT in the evaluation of response to treatment.
Finessi, M., Bellò, M., Giunta, F. P., Veltri, A., & Deandreis, D. (2018). Interventional locoregional treatment and metabolic response: advantages of using PET/CT in the evaluation of response to treatment. Q J Nucl Med Mol Imaging, 62(2), 165-184. doi:10.23736/s1824-4785.17.03037-0
- 2018
Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0 (2018)
Law, I., Albert, N. L., Arbizu, J., Boellaard, R., Drzezga, A., Galldiks, N., . . . Weller, M. (2019). Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0. European Journal of Nuclear Medicine and Molecular Imaging, 46(3), 540-557. Retrieved from https://doi.org/10.1007/s00259-018-4207-9. doi:10.1007/s00259-018-4207-9
- 2018
MRI and PET/CT for evaluation of the pathological response to neoadjuvant chemotherapy in breast cancer: A systematic review and meta-analysis.
Li, H., Yao, L., Jin, P., Hu, L., Li, X., Guo, T., & Yang, K. (2018). MRI and PET/CT for evaluation of the pathological response to neoadjuvant chemotherapy in breast cancer: A systematic review and meta-analysis. Breast, 40, 106-115. doi:10.1016/j.breast.2018.04.018
- 2018
MRI and PET/CT for evaluation of the pathological response to neoadjuvant chemotherapy in breast cancer: A systematic review and meta-analysis.
Li, H., Yao, L., Jin, P., Hu, L., Li, X., Guo, T., & Yang, K. (2018). MRI and PET/CT for evaluation of the pathological response to neoadjuvant chemotherapy in breast cancer: A systematic review and meta-analysis. Breast, 40, 106-115. doi:10.1016/j.breast.2018.04.018
- 2018
Non-small cell lung cancer brain metastasis screening in the era of positron emission tomography-CT staging: Current practice and outcomes.
Diaz, M. E., Debowski, M., Hukins, C., Fielding, D., Fong, K. M., & Bettington, C. S. (2018). Non-small cell lung cancer brain metastasis screening in the era of positron emission tomography-CT staging: Current practice and outcomes. J Med Imaging Radiat Oncol, 62(3), 383-388. doi:10.1111/1754-9485.12732
- 2018
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
Antonia, S. J. V., Augusto: Daniel, Davey: Vicente, David: Murakami, Shuji: Hui, Rina: Kurata, Takayasu: Chiappori, Alberto: Lee, Ki H.: de Wit, Maike: Cho, Byoung C.: Bourhaba, Maryam: Quantin, Xavier: Tokito, Takaaki: Mekhail, Tarek: Planchard, David: Kim, Young-Chul: Karapetis, Christos S.: Hiret, Sandrine: Ostoros, Gyula: Kubota, Kaoru: Gray, Jhanelle E.: Paz-Ares, Luis: de Castro Carpeño, Javier: Faivre-Finn, Corinne: Reck, Martin: Vansteenkiste, Johan: Spigel, David R.: Wadsworth, Catherine: Melillo, Giovanni: Taboada, Maria: Dennis, Phillip A.: Özgüroğlu, Mustafa. (2018).
- 2018
Performance of F-18 FDG PET/CT for predicting malignant potential of gastrointestinal stromal tumors: A systematic review and meta-analysis.
Kim, S. J., & Lee, S. W. (2018b). Performance of F-18 FDG PET/CT for predicting malignant potential of gastrointestinal stromal tumors: A systematic review and meta-analysis. J Gastroenterol Hepatol, 33(3), 576-582. doi:10.1111/jgh.14015
- 2018
Performance of pre-treatment ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography for detecting metastasis in ovarian cancer: a systematic review and meta-analysis.
Han, S., Woo, S., Suh, C. H., & Lee, J. J. (2018). Performance of pre-treatment ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography for detecting metastasis in ovarian cancer: a systematic review and meta-analysis. J Gynecol Oncol, 29(6), e98. doi:10.3802/jgo.2018.29.e98
- 2018
PET-PANC: multicentre prospective diagnostic accuracy and health economic analysis study of the impact of combined modality 18fluorine-2-fluoro-2-deoxy-d-glucose positron emission tomography with computed tomography scanning in the diagnosis and management of pancreatic cancer.
Ghaneh, P., Hanson, R., Titman, A., Lancaster, G., Plumpton, C., Lloyd-Williams, H., . . . Neoptolemos, J. P. (2018). PET-PANC: multicentre prospective diagnostic accuracy and health economic analysis study of the impact of combined modality 18fluorine-2-fluoro-2-deoxy-d-glucose positron emission tomography with computed tomography scanning in the diagnosis and management of pancreatic cancer. Health Technol Assess, 22(7), 1-114. doi:10.3310/hta22070
- 2018
PET/CT for Lymphoma Post-therapy Response Assessment in Other Lymphomas, Response Assessment for Autologous Stem Cell Transplant, and Lymphoma Follow-up.
Karls, S., Shah, H., & Jacene, H. (2018). PET/CT for Lymphoma Post-therapy Response Assessment in Other Lymphomas, Response Assessment for Autologous Stem Cell Transplant, and Lymphoma Follow-up. Semin Nucl Med, 48(1), 37-49. doi:10.1053/j.semnuclmed.2017.09.004
- 2018
PET/CT for Lymphoma Post-therapy Response Assessment in Other Lymphomas, Response Assessment for Autologous Stem Cell Transplant, and Lymphoma Follow-up.
Karls, S., Shah, H., & Jacene, H. (2018). PET/CT for Lymphoma Post-therapy Response Assessment in Other Lymphomas, Response Assessment for Autologous Stem Cell Transplant, and Lymphoma Follow-up. Semin Nucl Med, 48(1), 37-49. doi:10.1053/j.semnuclmed.2017.09.004
- 2018
PET/CT in Lymphoma: Current Overview and Future Directions.
Cheson, B. D. (2018). PET/CT in Lymphoma: Current Overview and Future Directions. Semin Nucl Med, 48(1), 76-81. doi:10.1053/j.semnuclmed.2017.09.007
- 2018
Positron emission tomography (PET) and magnetic resonance imaging (MRI) for assessing tumour resectability in advanced epithelial ovarian/fallopian tube/primary peritoneal cancer.
Roze, J. F., Hoogendam, J. P., van de Wetering, F. T., Spijker, R., Verleye, L., Vlayen, J., . . . Zweemer, R. P. (2018). Positron emission tomography (PET) and magnetic resonance imaging (MRI) for assessing tumour resectability in advanced epithelial ovarian/fallopian tube/primary peritoneal cancer. Cochrane Database Syst Rev, 10(10), Cd012567. doi:10.1002/14651858.CD012567.pub2
- ‹ previous
- 5 of 11
- next ›